Suppr超能文献

终末期肾病患者队列中自发性肌腱断裂发病率与肾性骨病的关联。

Association of incidence rate of spontaneous tendon rupture and renal bone disease in end-stage renal disease patients' cohort.

作者信息

Koh Keng-Hee, Arimuthu Durga Arinandini

机构信息

Medical Department, Miri Hospital, Ministry of Health, Miri, Malaysia.

出版信息

Semin Dial. 2023 Nov-Dec;36(6):462-467. doi: 10.1111/sdi.13145. Epub 2023 May 12.

Abstract

INTRODUCTION

Spontaneous tendon rupture (STR) is one of the complications related to hyperparathyroidism. This study aims to verify this and to elucidate the feasibility of combined incidence rate of STR and bony fracture to assess clinical management of renal bone disease in dialysis cohort.

METHOD

This is a clinical audit of cases of STR and fracture with 5504 patient-year dialysis vintage over 10 years. In order to verify the risk factor, comparison of cases of tendon rupture, the gender, and dialysis vintage matched patients without tendon rupture were done, followed by comparison with post-parathyroidectomy patients.

RESULT

Six cases of STR involving eight tendons were identified, including a case of concurrent tendon rupture and bony fracture. These include two cases of double tendons ruptures. During this time, there were 15 cases of bony fracture without tendon rupture. The overall incidence rate for STR and fracture was of 0.0011 and 0.0029 incidence per year of dialysis vintage or one case per 917 and 344 patient-year dialysis vintage, respectively. For patients with PTH ≥ 600 pg/mL, the incidence rate of tendon rupture and fracture was 0.0199 and 0.0430 incidence per person-years or one case per 50 and 23 person-years, respectively. For patients with PTH < 600 pg/mL, the respective rate was 0 and 0.0006 incidence per person-years or one case per >5202 and 1734 person-years. There was significant difference for incidence rates of tendon rupture and fracture between these two groups, with six incidences of tendon rupture per 302 patient-dialysis-years of PTH ≥ 600 pg/mL versus 0 incidence per 5202 patient-year dialysis vintage of PTH < 600 pg/mL (p < 0.001). In similar comparison, there was also significant difference for incidence rate of fracture with 13/302 versus 2/5202 (p < 0.001). In the 5 yearly audit over 10 years, the incidence rates of tendon rupture and fracture have dropped from 0.0052 to 0.0028 or one incidence per 192 to 356 person-years. Among 35 patients post-parathyroidectomy, there was an incidence of tendon rupture in a patient with recurrence of hyperparathyroidism, 5 years after surgery. Comparing six survived patients with tendon rupture versus 12 age-gender-dialysis vintage matched patients, hyperparathyroidism has been shown to be most important risk factor. And subsequently, comparing them with six post-parathyroidectomy patients, reduction of alkaline phosphatase (ALP) has been shown to be associated with lower risk of tendon rupture. Median survival in patients with history of tendon rupture and those with history of fracture was 5.9 and 2.2 years, respectively (p = 0.192).

CONCLUSION

Although rare, end-stage renal failure patients on dialysis with PTH > 600 pg/mL had high risk of tendon rupture and bony fracture. Parathyroidectomy might reduce the risk of tendon rupture and fracture with lowering ALP signifying reduction in bone turn over. Combined incidence rate of tendon rupture and fracture could be used to assess the control of hyperparathyroidism related issues in dialysis center.

摘要

引言

自发性肌腱断裂(STR)是与甲状旁腺功能亢进相关的并发症之一。本研究旨在证实这一点,并阐明STR与骨折合并发生率评估透析队列中肾性骨病临床管理的可行性。

方法

这是一项对10年间5504患者年透析龄的STR和骨折病例的临床审计。为了验证风险因素,对肌腱断裂病例、性别以及透析龄匹配的无肌腱断裂患者进行了比较,随后与甲状旁腺切除术后患者进行了比较。

结果

共识别出6例STR累及8条肌腱,包括1例同时发生肌腱断裂和骨折的病例。其中有2例双肌腱断裂。在此期间,有15例无肌腱断裂的骨折病例。STR和骨折的总体发生率分别为每年透析龄0.0011和0.0029,即每917和344患者年透析龄1例。对于甲状旁腺激素(PTH)≥600 pg/mL的患者,肌腱断裂和骨折的发生率分别为每人年0.0199和0.0430,即每50和23人年1例。对于PTH<600 pg/mL的患者,相应发生率分别为每人年0和0.0006,即每>5202和1734人年1例。这两组之间肌腱断裂和骨折的发生率存在显著差异,PTH≥600 pg/mL的患者每302患者透析年有6例肌腱断裂,而PTH<600 pg/mL的患者每5202患者年透析龄发生率为0(p<0.001)。在类似比较中,骨折发生率也有显著差异,分别为13/302和2/5202(p<0.001)。在10年的5年一次审计中,肌腱断裂和骨折的发生率从0.0052降至0.0028,即每192至356人年1例。在35例甲状旁腺切除术后患者中,1例患者在术后5年甲状旁腺功能亢进复发时发生了肌腱断裂。将6例存活的肌腱断裂患者与12例年龄、性别、透析龄匹配的患者进行比较,结果显示甲状旁腺功能亢进是最重要的风险因素。随后,将他们与6例甲状旁腺切除术后患者进行比较,结果显示碱性磷酸酶(ALP)降低与肌腱断裂风险降低相关。有肌腱断裂病史和有骨折病史的患者的中位生存期分别为5.9年和2.2年(p = 0.192)。

结论

尽管罕见,但透析的终末期肾衰竭患者PTH>600 pg/mL时肌腱断裂和骨折风险较高。甲状旁腺切除术可能通过降低ALP(表明骨转换降低)来降低肌腱断裂和骨折的风险。肌腱断裂和骨折的合并发生率可用于评估透析中心甲状旁腺功能亢进相关问题的控制情况。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验